Rochester, NY — June 8, 2026 — Resiliélle®, an international leader in regenerative aesthetics and the world’s leading manufacturer of Certified Age Zero™ Exosomes, today announced that Synergy Aesthetics will serve as the exclusive representative for the Age Zero™ Exosome platform throughout a ten-state Midwest territory including Arkansas, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, South Dakota, and Wisconsin. [Read more…]
The Rise of Stem Cell Exosomes and their Applications
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. In the early 1960s, Ernest A. McCulloch and James E. started several experiments leading to the discovery of stem cells. It was not until much later in 1987 that exosomes were first identified in a mammalian reticulocyte (red blood cell)[1] and not until 2007 that exosome-mediated transfer of mRNAs and microRNAs was identified as a “novel mechanism of genetic exchange between cells.”[2] [Read more…]
Fall Pharma Conferences 2026: 10 Worth Attending in the Second Half of the Year
The fall pharma conferences of 2026 mark the season when the industry reconvenes after the summer congresses to turn the year’s science into commercial and operational decisions. [Read more…]
Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2026
The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has been 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]
L2 Bio, LLC Launches C-ROW Site Beta: A Breakthrough Research Project in Costa Rica Targeting Osteoarthritis
Innovative Participant-Funded Study Harnesses Enhanced Autologous Adipose-Derived Stem Cells to Combat Degenerative Joint Disease
ESCAZU, COSTA RICA, June 1, 2026 — L2 Bio, LLC has formally announced the launch of the C-ROW Site Beta (C-ROW), an innovative, participant-funded research project based in Costa Rica welcoming the safety and convenience of utilizing local participation of your USA or Canadian based doctor. The study centers on the use of enhanced autologous adipose-derived stem cells (ADSCs) to address the debilitating progression of osteoarthritis. [Read more…]
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 339
- Next Page »